NCT00004180View on ClinicalTrials.gov

Rosiglitazone in Treating Patients With Liposarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

March 31, 2006

Study Completion Date

May 31, 2015

Conditions
Sarcoma
Interventions
DRUG

rosiglitazone maleate

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00004180 - Rosiglitazone in Treating Patients With Liposarcoma | Biotech Hunter | Biotech Hunter